|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustments to reconcile net loss to cash (used in) provided by operating activities: | |||||
| Depreciation & amortization | |||||
| Impairment of assets | |||||
| Amortization of deferred financing fees and debt discount | |||||
| Bad debt expense | |||||
| Stock-based compensation expense | |||||
| Loss on disposal of assets | |||||
| Loss on exercise of equity classified warrants | |||||
| Provision for inventory obsolescence | |||||
| Gain on extinguishment of debt | |||||
| Change in fair value of warrant liabilities and derivatives | |||||
| Paid in kind interest on convertible notes | |||||
| Non-cash lease expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Proceeds from tenant improvement allowances | |||||
| Other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Proceeds from sale of investments | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Payments of finance fees | |||||
| Payments of transaction costs | |||||
| Payment of deferred underwriting fees | |||||
| Payment of restricted stock units held for taxes | |||||
| Payment of finance lease obligations | |||||
| Proceeds from equity infusion from the Merger, net of redemptions | |||||
| Proceeds from PIPE issuance | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from issuance of common stock under ESPP | |||||
| Proceeds from the exercise of warrants | |||||
| Payments to repurchase common stock | |||||
| Excise tax from stock repurchases | |||||
| Payments of long-term debt | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—BEGINNING OF PERIOD | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—END OF PERIOD | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||
| Cash paid for interest | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Lease modification and termination | |||||
| Conversion of preferred stock to common stock | |||||
| Issuance of common stock related to convertible notes | |||||
| 2025 Convertible Notes | |||||
| Capital contribution related to extinguishment of debt | |||||
| Issuance of common stock related to cashless exercise of liability classified warrants | |||||
| Establishment of operating lease | |||||
| RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH: | |||||
| Cash and cash equivalents | |||||
| Restricted cash—prepaid expenses and other current assets, other noncurrent assets | |||||
Loading...